BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Clinical trial NCT07492641 · RECRUITING

Trial details

NCT number: NCT07492641
Sponsor: BeOne Medicines
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HR+/HER2- Breast Cancer

Start date: 2026-05-22
Primary completion: 2029-04-01
Enrollment: 1056

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.